Recent Software Developments and Applications in Functional Imaging

Current Pharmaceutical Biotechnology

Volumn 13, Issue 11, 2012, Pages 2166-2181

  Wen, Lingfeng ^a,b   Eberl, Stefan ^a,b   Fulham, Michael ^a,b,c   Feng, Dagan ^b,d  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Image correction; Kinetic modelling; Motion correction; PET; SPECT

Indexed keywords

3 (2 AZETIDINYLMETHOXY) PYRIDINE; BENZODIAZEPINE RECEPTOR; CANNABINOID 1 RECEPTOR; CONTRAST MEDIUM; DIPRENORPHINE; FLUMAZENIL C 11; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; IOMAZENIL I 123; RACLOPRIDE C 11; SEROTONIN TRANSPORTER; TRACER; UNCLASSIFIED DRUG;

ALGORITHM; ALZHEIMER DISEASE; ATTENUATION; COMPARTMENT MODEL; COMPUTER PROGRAM; DECISION TREE; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; IMAGING; KINETICS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; PROSTATE CANCER; RECEPTOR BINDING; REVIEW; SIGNAL NOISE RATIO; SIMULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTROSCOPY; WAVELET ANALYSIS;

ANIMALS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; POSITRON-EMISSION TOMOGRAPHY; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873432280     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112802502015     Document Type: Review

References (170)

1. Beyer, T.; Townsend, D.W.; Brun, T.; Kinahan, P.E.; Charron, M.; Roddy, R.; Jerin, J.; Young, J.; Byars, L.; Nutt, R. A combined PET/CT scanner for clinical oncology. J. Nucl. Med., 2000, 41(8), 1369-1379.
2. Blankespoor, S.C.; Wu, X.; Kalki, K.; Brown, J.K.; Tang, H.R.; Cann, C.E.; Hasegawa, B.H. Attenuation correction of SPECT using X-ray CT on an emission-transmission CT system: Myocardial perfusion assessment. IEEE Trans. Nucl. Sci., 1996, 43(4), 2263-2274.
3. Schlemmer, H.P.W.; Pichler, B.J.; Schmand, M.; Burbar, Z.; Michel, C.; Ladebeck, R.; Jattke, K.; Townsend, D.; Nahmias, C.; Jacob, P.K.; Heiss, W.D.; Claussen, C.D. Simultaneous MR/PET imaging of the human brain: Feasibility study. Radiology, 2008, 248(3), 1028-1035.
4. Ratib, O.; Becker, M.; Vallée, J.P.; Loubeyre, P.; Wissmeyer, M.; Willi, J.-P.; Steiner, C.; Rager, O.; Garibotto, V.; Viallon, M. Whole body PET-MRI scanner: First experience in oncology. J. Nucl. Med., 2010, 51(Suppl. 2), 165.
5. Zaidi, H.; Montandon, M.L.; Meikle, S. Strategies for attenuation compensation in neurological PET studies. Neuroimage, 2007, 34(2), 518-541.
6. Schafers, K.P.; Stegger, L. Combined imaging of molecular function and morphology with PET/CT and SPECT/CT: Image fusion and motion correction. Basic Res. Cardiol., 2008, 103(2), 191-199.
7. Gunn, R.N.; Gunn, S.R.; Cunningham, V.J. Positron emission tomography compartmental models. J. Cereb. Blood Flow Metab., 2001, 21(6), 635-652.
8. Ichise, M.; Meyer, J.H.; Yonekura, Y. An introduction to PET and SPECT neuroreceptor quantification models. J. Nucl. Med., 2001, 42(5), 755-763.
9. Zaidi, H.; El Naqa, I. PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques. Eur. J. Nucl. Med. Mol. Imaging, 2010, 37(11), 2165-2187.
10. Ahmadian, A.; Ay, M.R.; Bidgoli, J.H.; Sarkar, S.; Zaidi, H. Correction of oral contrast artifacts in CT-based attenuation correction of PET images using an automated segmentation algorithm. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35(10), 1812-1823.
11. Rehfeld, N.S.; Heismann, B.J.; Kupferschläger, J.; Aschoff, P.; Christ, G.; Pfannenberg, A.C.; Pichler, B.J. Single and dual energy attenuation correction in PET/CT in the presence of iodine based contrast agents. Med. Phys., 2008, 35(5), 1959-1969.
12. Hofmann, M.; Steinke, F.; Scheel, V.; Charpiat, G.; Farquhar, J.; Aschoff, P.; Brady, M.; Schölkopf, B.; Pichler, B.J. MRI-based attenuation correction for PET/MRI: A novel approach combining pattern recognition and atlas registration. J. Nucl. Med., 2008, 49(11), 1875-1883.
13. Martinez-Moller, A.; Souvatzoglou, M.; Delso, G.; Bundschuh, R.A.; Chefd'hotel, C.; Ziegler, S.I.; Navab, N.; Schwaiger, M.; Nekolla, S.G. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: Evaluation with PET/CT data. J. Nucl. Med., 2009, 50(4), 520-526.
14. Hofmann, M.; Pichler, B.; Schölkopf, B.; Beyer, T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(Suppl. 1), 93-104.
15. Mikhno, A.; Devanand, D.; Pelton, G.; Cuasay, K.; Gunn, R.; Upton, N.; Lai, R.Y.; Libri, V.; Mann, J.J.; Parsey, R.V. Voxelbased analysis of 11C-PIB scans for diagnosing Alzheimer's disease. J. Nucl. Med., 2008, 49(8), 1262-1269.
16. Samuraki, M.; Matsunari, I.; Chen, W.P.; Yajima, K.; Yanase, D.; Fujikawa, A.; Takeda, N.; Nishimura, S.; Matsuda, H.; Yamada, M. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34(10), 1658-1669.
17. Giovacchini, G.; Bonwetsch, R.; Herscovitch, P.; Carson, R.E.; Theodore, W.H. Cerebral blood flow in temporal lobe epilepsy: a partial volume correction study. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34(12), 2066-2072.
18. Kato, H.; Shimosegawa, E.; Oku, N.; Kitagawa, K.; Kishima, H.; Saitoh, Y.; Kato, A.; Yoshimine, T.; Hatazawa, J. MRI-based correction for partial-volume effect improves detectability of intractable epileptogenic foci on 123I-iomazenil brain SPECT images. J. Nucl. Med., 2008, 49(3), 383-389.
19. Rousset, O.G.; Collins, D.L.; Rahmim, A.; Wong, D.F. Design and implementation of an automated partial volume correction in PET: Application to dopamine receptor quantification in the normal human striatum. J. Nucl. Med., 2008, 49(7), 1097-1106.
20. Mourik, J.E.M.; Lubberink, M.; Klumpers, U.M.H.; Comans, E.F.; Lammertsma, A.A.; Boellaard, R. Partial volume corrected image derived input functions for dynamic PET brain studies: Methodology and validation for [11C]flumazenil. Neuroimage, 2008, 39(3), 1041-1050.
21. Bataille, F.; Comtat, C.; Jan, S.; Sureau, F.C.; Trébossen, R. Brain PET partial-volume compensation using blurred anatomical labels. IEEE Trans. Nucl. Sci., 2007, 54(5), 1606-1615.
22. Barbee, D.L.; Flynn, R.T.; Holden, J.E.; Nickles, R.J.; Jeraj, R. A method for partial volume correction of PET-imaged tumor heterogeneity using expectation maximization with a spatially varying point spread function. Phys. Med. Biol., 2010, 55(1), 221-236.
23. De Bernardi, E.; Faggiano, E.; Zito, F.; Gerundini, P.; Baselli, G. Lesion quantification in oncological positron emission tomography: A maximum likelihood partial volume correction strategy. Med. Phys., 2009, 36(7), 3040-3049.
24. Shidahara, M.; Tsoumpas, C.; Hammers, A.; Boussion, N.; Visvikis, D.; Suhara, T.; Kanno, I.; Turkheimer, F.E. Functional and structural synergy for resolution recovery and partial volume correction in brain PET. Neuroimage, 2009, 44(2), 340-348.
25. Kirov, A.S.; Piao, J.Z.; Schmidtlein, C.R. Partial volume effect correction in PET using regularized iterative deconvolution with variance control based on local topology. Phys. Med. Biol., 2008, 53(10), 2577-2591.
26. Teo, B.K.; Seo, Y.; Bacharach, S.L.; Carrasquillo, J.A.; Libutti, S.K.; Shukla, H.; Hasegawa, B.H.; Hawkins, R.A.; Franc, B.L. Partial-volume correction in PET: Validation of an iterative postreconstruction method with phantom and patient data. J. Nucl. Med., 2007, 48(5), 802-810.
27. Tohka, J.; Reilhac, A. Deconvolution-based partial volume correction in Raclopride-PET and Monte Carlo comparison to MRbased method. Neuroimage, 2008, 39(4), 1570-1584.
28. Boussion, N.; Le Rest, C.C.; Hatt, M.; Visvikis, D. Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(7), 1064-1075.
29. Shidahara, M.; Ikoma, Y.; Seki, C.; Fujimura, Y.; Naganawa, M.; Ito, H.; Suhara, T.; Kanno, I.; Kimura, Y. Wavelet denoising for voxel-based compartmental analysis of peripheral benzodiazepine receptors with 18F-FEDAA1106. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35(2), 416-423.
30. Yaqub, M.; Boellaard, R.; Schuitemaker, A.; van Berckel, B.N.M.; Lammertsma, A.A. Impact of wavelet based denoising of [11C](R)-PK11195 time activity curves on accuracy and precision of kinetic analysis. Med. Phys., 2008, 35(11), 5069-5078.
31. Turkheimer, F.E.; Boussion, N.; Anderson, A.N.; Pavese, N.; Piccini, P.; Visvikis, D. PET image denoising using a synergistic multiresolution analysis of structural (MRI/CT) and functional datasets. J. Nucl. Med., 2008, 49(4), 657-666.
32. Feng, D.; Wen, L.; Eberl, S. Techniques for parametric imaging. In: Biomedical Information Technology; Feng, D., Eds.; Elsevier press: San Diego, 2007; pp. 137-163.
33. Akaike, H. A new look at the statistical model identification. IEEE Trans. Automat. Contr., 1974, 19, 716-723.
34. Schwarz, G. Estimating the dimension of a model. Ann. Statist., 1978, 6, 461-564.
35. Carson, R.E. Parameter estimation in positron emission tomography. In: Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart; Phelps, M.E., Mazziotta, J.C., Shelbert, H.R., Eds.; Raven Press: New York, 1986; pp. 347-390.
36. Chen, S.; Feng, D. Evaluation of hepatocellular carcinoma with dynamic 11C-acetate PET: A dual-modeling method. IEEE Trans. Nucl. Sci., 2008, 55(3), 999-1007.
37. de Jong, H.W.A.M.; Rijzewijk, L.J.; Lubberink, M.; van der Meer, R.W.; Lamb, H.J.; Smit, J.W.A.; Diamant, M.; Lammertsma, A.A. Kinetic models for analysing myocardial [11C]palmitate data. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(6), 966-978.
38. Schiepers, C.; Hoh, C.K.; Nuyts, J.; Seltzer, M.; Wu, C.; Huang, S.C.; Dahlbom, M. 1-11C-acetate kinetics of prostate cancer. J. Nucl. Med., 2008, 49(2), 206-215.
39. Schiepers, C.; Chen, W.; Cloughesy, T.; Dahlbom, M.; Huang, S.C. 18F-FDOPA kinetics in brain tumors. J. Nucl. Med., 2007, 48(10), 1651-1661.
40. Nye, J.A.; Votaw, J.R.; Jarkas, N.; Purselle, D.; Camp, V.; Bremner, J.D.; Kilts, C.D.; Nemeroff, C.B.; Goodman, M.A. Compartmental modeling of 11C-HOMADAM binding to the serotonin transporter in the healthy human brain. J. Nucl. Med., 2008, 49(12), 2018-2025.
41. Lubberink, M.; Luurtsema, G.; van Berckel, B.N.M.; Boellaard, R.; Toornvliet, R.; Windhorst, A.D.; Franssen, E.J.F.; Lammertsma, A.A. Evaluation of tracer kinetic models for quantification of Pglycoprotein function using (R)-[11C]verapamil and PET. J. Cereb. Blood Flow Metab., 2007, 27(2), 424-433.
42. Ferl, G.Z.; Dumont, R.A.; Hildebrandt, I.J.; Armijo, A.; Haubner, R.; Reischl, G.; Su, H.; Weber, W.A.; Huang, S.C. Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice. J. Nucl. Med., 2009, 50(2), 250-258.
43. Wyss, M.T.; Ametamey, S.M.; Treyer, V.; Bettio, A.; Blagoev, M.; Kessler, L.J.; Burger, C.; Weber, B.; Schmidt, M.; Gasparini, F.; Buck, A. Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a scintillator. Neuroimage, 2007, 35(3), 1086-1092.
44. Iida, H.; Eberl, S.; Kim, K.M.; Tamura, Y.; Ono, Y.; Nakazawa, M.; Sohlberg, A.; Zeniya, T.; Hayashi, T.; Watabe, H. Absolute quantitation of myocardial blood flow with 201Tl and dynamic SPECT in canine: optimisation and validation of kinetic modelling. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35(5), 896-905.
45. de Langen, A.J.; Lubberink, M.; Boellaard, R.; Spreeuwenberg, M.D.; Smit, E.F.; Hoekstra, O.S.; Lammertsma, A.A. Reproducibility of tumor perfusion measurements using 15Olabeled water and PET. J. Nucl. Med., 2008, 49(11), 1763-1768.
46. Frost, M.L.; Blake, G.M.; Park-Holohan, S.J.; Cook, G.J.R.; Curran, K.M.; Marsden, P.K.; Fogelman, I. Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. J. Nucl. Med., 2008, 49(5), 700-707.
47. Mourik, J.E.M.; Lubberink, M.; Schuitemaker, A.; Tolboom, N.; van Berckel, B.N.M.; Lammertsma, A.A.; Boellaard, R. Imagederived input functions for PET brain studies. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(3), 463-471.
48. Schroeder, T.; Melo, M.F.V.; Musch, G.; Harris, R.S.; Venegas, J.G.; Winkler, T. Image-derived input function for assessment of 18F-FDG uptake by the inflamed lung. J. Nucl. Med., 2007, 48(11), 1889-1896.
49. Backes, H.; Ullrich, R.; Neumaier, B.; Kracht, L.; Wienhard, K.; Jacobs, A.H. Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(12), 1960-1967.
50. Chen, K.; Chen, X.; Renaut, R.; Alexander, G.E.; Bandy, D.; Guo, H.; Reiman, E.M. Characterization of the image-derived carotid artery input function using independent component analysis for the quantitation of [18F] fluorodeoxyglucose positron emission tomography images. Phys. Med. Biol., 2007, 52(23), 7055-7071.
51. Zanotti-Fregonara, P.; Maroy, R.; Comtat, C.; Jan, S.; Gaura, V.; Bar-Hen, A.; Ribeiro, M.J.; Trébossen, R. Comparison of 3 methods of automated internal carotid segmentation in human brain PET studies: Application to the estimation of arterial input function. J. Nucl. Med., 2009, 50(3), 461-467.
52. Kudomi, N.; Slimani, L.; Järvisalo, M.J.; Kiss, J.; Lautamaki, R.; Naum, G.A.; Savunen, T.; Knuuti, J.; Iida, H.; Nuutila, P.; Iozzo, P. Non-invasive estimation of hepatic blood perfusion from H2 15O PET images using tissue-derived arterial and portal input functions. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35(10), 1899-1911.
53. Kudomi, N.; Järvisalo, M.J.; Kiss, J.; Borra, R.; Viljanen, A.; Viljanen, T.; Savunen, T.; Knuuti, J.; Iida, H.; Nuutila, P.; Iozzo, P. Non-invasive estimation of hepatic glucose uptake from [18F]FDG PET images using tissue-derived input functions. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(12), 2014-2026.
54. O'Sullivan, F.; Kirrane, J.; Muzi, M.; O'Sullivan, J.N.; Spence, A.M.; Mankoff, D.A.; Krohn, K.A. Kinetic quantitation of cerebral PET-FDG studies without concurrent blood sampling: statistical recovery of the arterial input function. IEEE Trans. Med. Imaging, 2010, 29(3), 610-624.
55. Vriens, D.; de Geus-Oei, L.F.; Oyen, W.J.G.; Visser, E.P. A curvefitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment. J. Nucl. Med., 2009, 50(12), 1933-1939.
56. Yu, A.S.; Lin, H.D.; Huang, S.C.; Phelps, M.E.; Wu, H.M. Quantification of cerebral glucose metabolic rate in mice using 18FFDG and small-animal PET. J. Nucl. Med., 2009, 50(6), 966-973.
57. Kim, S.J.; Lee, J.S.; Im, K.C.; Kim, S.Y.; Park, S.A.; Lee, S.J.; Oh, S.J.; Lee, D.S.; Moon, D.H. Kinetic modeling of 3'-deoxy-3'-18Ffluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice. J. Nucl. Med., 2008, 49(12), 2057-2066.
58. Fang, Y.H.D.; Muzic, R.F. Spillover and partial-volume correction for image-derived input functions for small-animal 18F-FDG PET studies. J. Nucl. Med., 2008, 49(4), 606-614.
59. Ferl, G.Z.; Zhang, X.L.; Wu, H.M.; Huang, S.C. Estimation of the 18F-FDG input function in mice by use of dynamic small-animal PET and minimal blood sample data. J. Nucl. Med., 2007, 48(12), 2037-2045.
60. Bishu, S.; Schmidt, K.C.; Burlin, T.; Channing, M.; Conant, S.; Huang, T.J.; Liu, Z.H.; Qin, M.; Unterman, A.; Xia, Z.Y.; Zametkin, A.; Herscovitch, P.; Smith, C.B. Regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility. J. Cereb. Blood Flow Metab., 2008, 28(8), 1502-1513.
61. Bishu, S.; Schmidt, K.C.; Burlin, T.V.; Channing, M.A.; Horowitz, L.; Huang, T.J.; Liu, Z.H.; Qin, M.; Vuong, B.K.; Unterman, A.J.; Xia, Z.Y.; Zametkin, A.; Herscovitch, P.; Quezado, Z.; Smith, C.B. Propofol anesthesia does not alter regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in healthy male subjects. J. Cereb. Blood Flow Metab., 2009, 29(5), 1035-1047.
62. Brown, A.K.; Kimura, Y.; Zoghbi, S.S.; Simeon, F.G.; Liow, J.S.; Kreisl, W.C.; Tau, A.; Fujita, M.; Pike, V.W.; Innis, R.B. Metabotropic glutamate subtype 5 receptors are quantified in the human brain with a novel radioligand for PET. J. Nucl. Med., 2008, 49(12), 2042-2048.
63. Terry, G.E.; Liow, J.S.; Zoghbi, S.S.; Hirvonen, J.; Farris, A.G.; Lerner, A.; Tauscher, J.T.; Schaus, J.M.; Phebus, L.; Felder, C.C.; Morse, C.L.; Hong, J.S.; Pike, V.W.; Halldin, C.; Innis, R.B. Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand. Neuroimage, 2009, 48(2), 362-370.
64. Sakata, M.; Kimura, Y.; Naganawa, M.; Oda, K.; Ishii, K.; Chihara, K.; Ishiwata, K. Mapping of human cerebral sigma, receptors using positron emission tomography and [11C]SA4503. Neuroimage, 2007, 35(1), 1-8.
65. El Fakhri, G.; Kardan, A.; Sitek, A.; Dorbala, S.; Abi-Hatem, N.; Lahoud, Y.; Fischman, A.; Coughlan, M.; Yasuda, T.; Di Carli, M.F. Reproducibility and accuracy of quantitative myocardial blood flow assessment with 82Rb PET: Comparison with 13NAmmonia PET. J. Nucl. Med., 2009, 50(7), 1062-1071.
66. Nishiyama, Y.; Yamamoto, Y.; Monden, T.; Sasakawa, Y.; Kawai, N.; Satoh, K.; Ohkawa, M. Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34(1), 78-86.
67. Mosconi, L.; Tsui, W.H.; Rusinek, H.; De Santi, S.; Li, Y.; Wang, G.J.; Pupi, A.; Fowler, J.; de Leon, M.J. Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34(9), 1467-1479.
68. Lodge, M.A.; Jacene, H.A.; Pili, R.; Wahl, R.L. Reproducibility of tumor blood flow quantification with 15O-water PET. J. Nucl. Med., 2008, 49(10), 1620-1627.
69. Odano, I.; Halldin, C.; Karlsson, P.; Varrone, A.; Airaksinen, A.J.; Krasikova, R.N.; Farde, L. [18F]Flumazenil binding to central benzodiazepine receptor studies by PET-Quantitative analysis and comparisons with [11C]flumazenil. Neuroimage, 2009, 45(3), 891-902.
70. Fujimura, Y.; Zoghbi, S.S.; Simèon, F.G.; Taku, A.; Pike, V.W.; Innis, R.B.; Fujita, M. Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, 18FPBR06. J. Nucl. Med., 2009, 50(7), 1047-1053.
71. Imaizumi, M.; Briard, E.; Zoghbi, S.S.; Gourley, J.P.; Hong, J.; Fujimura, Y.; Pike, V.W.; Innis, R.B.; Fujita, M. Brain and wholebody imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage, 2008, 39(3), 1289-1298.
72. Miyoshi, M.; Ito, H.; Arakawa, R.; Takahashi, H.; Takano, H.; Higuchi, M.; Okumura, M.; Otsuka, T.; Kodaka, F.; Sekine, M.; Sasaki, T.; Fujie, S.; Seki, C.; Maeda, J.; Nakao, R.; Zhang, M.R.; Fukumura, T.; Matsumoto, M.; Suhara, T. Quantitative analysis of peripheral benzodiazepine receptor in the human brain using PET with 11C-AC-5216. J. Nucl. Med., 2009, 50(7), 1095-1101.
73. Wen, L.F.; Eberl, S.; Feng, D.G.; Cai, W.D.; Bai, J. Fast and reliable estimation of multiple parametric images using an integrated method for dynamic SPECT. IEEE Trans. Med. Imaging, 2007, 26(2), 179-189.
74. Wen, L.F.; Eberl, S.; Fulham, M.J.; Feng, D.; Bai, J. Constructing reliable parametric images using enhanced GLLS for dynamic SPECT. IEEE Trans. Biomed. Eng., 2009, 56(4), 1117-1126.
75. Cunningham, V.J.; Jones, T. Spectral analysis of dynamic PET studies. J. Cereb. Blood Flow Metab., 1993, 13(1), 15-23.
76. Edison, P.; Brooks, D.J.; Turkheimer, F.E.; Archer, H.A.; Hinz, R. Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility. Neuroimage, 2009, 48(2), 329-338.
77. Hinz, R.; Selvaraj, S.; Murthy, N.V.; Bhagwagar, Z.; Taylor, M.; Cowen, P.J.; Grasby, P.M. Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls. J. Cereb. Blood Flow Metab., 2008, 28(8), 1478-1490.
78. Hammers, A.; Asselin, M.C.; Turkheimer, F.E.; Hinz, R.; Osman, S.; Hotton, G.; Brooks, D.J.; Duncan, J.S.; Koepp, M.J. Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C]diprenorphine test-retest data. Neuroimage, 2007, 38(1), 82-94.
79. Turkheimer, F.E.; Edison, P.; Pavese, N.; Roncaroli, F.; Anderson, A.N.; Hammers, A.; Gerhard, A.; Hinz, R.; Tai, Y.F.; Brooks, D.J. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J. Nucl. Med., 2007, 48(1), 158-167.
80. Patlak, C.S.; Blasberg, R.G.; Fenstermacher, J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab., 1983, 3(1), 1-7.
81. Visser, E.P.; Philippens, M.E.P.; Kienhorst, L.; Kaanders, J.; Corstens, F.H.M.; de Geus-Oei, L.F.; Oyen, W.J.G. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET. J. Nucl. Med., 2008, 49(6), 892-898.
82. Juhász, C.; Muzik, O.; Xin, L.; Jahania, M.S.; Soubani, A.O.; Khalaf, M.; Peng, F.; Mangner, T.J.; Chakraborty, P.K.; Chugani, D.C. Quantification of tryptophan transport and metabolism in lung tumors using PET. J. Nucl. Med., 2009, 50(3), 356-363.
83. Ludolph, A.G.; Kassubek, J.; Schmeck, K.; Glaser, C.; Wunderlich, A.; Buck, A.K.; Reske, S.N.; Fegert, J.M.; Mottaghy, F.M. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: A 3,4-dihdroxy-6-[18F]fluorophenyl-L-alanine PET study. Neuroimage, 2008, 41(3), 718-727.
84. Menda, Y.; Ponto, L.L.B.; Dornfeld, K.J.; Tewson, T.J.; Watkins, G.L.; Schultz, M.K.; Sunderland, J.J.; Graham, M.M.; Buatti, J.M. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine (18F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy. J. Nucl. Med., 2009, 50(7), 1028-1035.
85. Logan, J.; Fowler, J.S.; Volkow, N.D.; Wolf, A.P.; Dewey, S.L.; Schlyer, D.J.; Macgregor, R.R.; Hitzemann, R.; Bendriem, B.; Gatley, S.J.; Christman, D.R. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab., 1990, 10(5), 740-747.
86. Kimes, A.S.; Chefer, S.I.; Matochik, J.A.; Contoreggi, C.S.; Vaupel, D.B.; Stein, E.A.; Mukhin, A.G. Quantification of nicotinic acetylcholine receptors in the human brain with PET: Bolus plus infusion administration of 2-[18F]F-A85380. Neuroimage, 2008, 39(2), 717-727.
87. Naganawa, M.; Kimura, Y.; Yano, J.; Mishina, M.; Yanagisawa, M.; Ishii, K.; Oda, K.; Ishiwata, K. Robust estimation of the arterial input function for Logan plots using an intersectional searching algorithm and clustering in positron emission tomography for neuroreceptor imaging. Neuroimage, 2008, 40(1), 26-34.
88. Kim, S.J.; Lee, J.S.; Kim, Y.K.; Frost, J.; Wand, G.; McCaul, M.E.; Lee, D.S. Multiple linear analysis methods for the quantification of irreversibly binding radiotracers. J. Cereb. Blood Flow Metab., 2008, 28(12), 1965-1977.
89. Zhou, Y.; Ye, W.G.; Brai, J.R.; Crabb, A.H.; Hilton, J.; Wong, D.F. A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies. Neuroimage, 2009, 44(3), 661-670.
90. Zhou, Y.; Ye, W.G.; Brai, J.R.; Wong, D.F. Multi-graphical analysis of dynamic PET. Neuroimage, 2010, 49(4), 2947-2957.
91. Lammertsma, A.A.; Hume, S.P. Simplified reference tissue model for PET receptor studies. Neuroimage, 1996, 4(3), 153-158.
92. Yaqub, M.; Boellaard, R.; van Berckel, B.N.M.; Ponsen, M.M.; Lubberink, M.; Windhorst, A.D.; Berendse, H.W.; Lammertsma, A.A. Quantification of dopamine transporter binding using [18F]FPbeta-CIT and positron emission tomography. J. Cereb. Blood Flow Metab., 2007, 27(7), 1397-1406.
93. Otsuka, T.; Ito, H.; Halldin, C.; Takahashi, H.; Takano, H.; Arakawa, R.; Okumura, M.; Kodaka, F.; Miyoshi, M.; Sekine, M.; Seki, C.; Nakao, R.; Suzuki, K.; Finnema, S.; Hirayasu, Y.; Suhara, T.; Farde, L. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-Propylnorapomorphine in the human brain. J. Nucl. Med., 2009, 50(5), 703-710.
94. Cervenka, S.; Bäckman, L.; Cselényi, Z.; Halldin, C.; Farde, L. Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum. Neuroimage, 2008, 40(3), 1287-1295.
95. Woodward, N.D.; Zald, D.H.; Ding, Z.H.; Riccardi, P.; Ansari, M.S.; Baldwin, R.M.; Cowan, R.L.; Li, R.; Kessler, R.M. Cerebral morphology and dopamine D2D3 receptor distribution in humans: A combined [18F]fallypride and voxel-based morphometry study. Neuroimage, 2009, 46(1), 31-38.
96. Asselin, M.C.; Montgomery, A.J.; Grasby, P.M.; Hume, S.P. Quantification of PET studies with the very high-affinity dopamine D2D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. J. Cereb. Blood Flow Metab., 2007, 27(2), 378-392.
97. Ikoma, Y.; Ito, H.; Arakawa, R.; Okumura, M.; Seki, C.; Shidahara, M.; Takahashi, H.; Kimura, Y.; Kanno, I.; Suhara, T. Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457. Neuroimage, 2008, 42(4), 1285-1294.
98. Jovanovic, H.; Lundberg, J.; Karlsson, P.; Cerin, A.; Saijo, T.; Varrone, A.; Halldin, C.; Nordström, A.L. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage, 2008, 39(3), 1408-1419.
99. Frey, B.N.; Rosa-Neto, P.; Lubarsky, S.; Diksic, M. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: A combined [11C]MT and [18F]MPPF positron emission tomography study. Neuroimage, 2008, 42(2), 850-857.
100. Okumura, M.; Arakawa, R.; Ito, H.; Seki, C.; Takahashi, H.; Takano, H.; Haneda, E.; Nakao, R.; Suzuki, H.; Suzuki, K.; Okubo, Y.; Suhara, T. Quantitative analysis of NK1 receptor in the human brain using PET with 18F-FE-SPA-RQ. J. Nucl. Med., 2008, 49(11), 1749-1755.
101. Klumpers, U.M.H.; Veltman, D.J.; Boellaard, R.; Comans, E.F.; Zuketto, C.; Yaqub, M.; Mourik, J.E.; Lubberink, M.; Hoogendijk, W.J.; Lammertsma, A.A. Comparison of plasma input and reference tissue models for analysing [11C]flumazenil studies. J. Cereb. Blood Flow Metab., 2008, 28(3), 579-587.
102. Hammers, A.; Panagoda, P.; Heckemann, R.A.; Kelsch, W.; Turkheimer, F.E.; Brooks, D.J.; Duncan, J.S.; Koepp, M.J. [11C]Flumazenil PET in temporal lobe epilepsy: do we need an arterial input function or kinetic modeling? J. Cereb. Blood Flow Metab., 2008, 28(1), 207-216.
103. Folkersma, H.; Boellaard, R.; Vandertop, W.P.; Kloet, R.W.; Lubberink, M.; Lammertsma, A.A.; van Berckel, B.N.M. Reference tissue models and blood-brain barrier disruption: Lessons from (R)-[11C]PK11195 in rraumatic brain injury. J. Nucl. Med., 2009, 50(12), 1975-1979.
104. Kropholler, M.A.; Boellaard, R.; van Berckel, B.N.M.; Schuitemaker, A.; Kloet, R.W.; Lubberink, M.J.; Jonker, C.; Scheltens, P.; Lammertsma, A.A. Evaluation of reference regions for (R)-[11C]PK11195 studies in Alzheimer's disease and mild cognitive impairment. J. Cereb. Blood Flow Metab., 2007, 27(12), 1965-1974.
105. Gunn, R.N.; Sargent, P.A.; Bench, C.J.; Rabiner, E.A.; Osman, S.; Pike, V.W.; Hume, S.P.; Grasby, P.M.; Lammertsma, A.A. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage, 1998, 8(4), 426-440.
106. Tomasi, G.; Edison, P.; Bertoldo, A.; Roncaroli, F.; Singh, P.; Gerhard, A.; Cobelli, C.; Brooks, D.J.; Turkheimer, F.E. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease. J. Nucl. Med., 2008, 49(8), 1249-1256.
107. Gunn, R.N.; Lammertsma, A.A.; Hume, S.P.; Cunningham, V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage, 1997, 6(4), 279-287.
108. Schuitemaker, A.; van Berckel, B.N.M.; Kropholler, M.A.; Veltman, D.J.; Scheltens, P.; Jonker, C.; Lammertsma, A.A.; Boellaard, R. SPM analysis of parametric (R)-[11C]PK11195 binding images: Plasma input versus reference tissue parametric methods. Neuroimage, 2007, 35(4), 1473-1479.
109. Wu, Y.J.; Carson, R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional Imaging. J. Cereb. Blood Flow Metab., 2002, 22(12), 1440-1452.
110. Fink, M.; Wadsak, W.; Savli, M.; Stein, P.; Moser, U.; Hahn, A.; Mien, L.K.; Kletter, K.; Mitterhauser, M.; Kasper, S.; Lanzenberger, R. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. Neuroimage, 2009, 45(2), 598-605.
111. Tolboom, N.; Yaqub, M.; Boellaard, R.; Luurtsema, G.; Windhorst, A.D.; Scheltens, P.; Lammertsma, A.A.; van Berckel, B.N.M. Testretest variability of quantitative [11C]PIB studies in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(10), 1629-1638.
112. Logan, J.; Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Ding, Y.S.; Alexoff, D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab., 1996, 16(5), 834-840.
113. Ng, S.; Villemagne, V.L.; Berlangieri, S.; Lee, S.T.; Cherk, M.; Gong, S.J.; Ackermann, U.; Saunder, T.; Tochon-Danguy, H.; Jones, G.; Smith, C.; O'Keefe, G.; Masters, C.L.; Rowe, C.C. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. J. Nucl. Med., 2007, 48(4), 547-552.
114. Wong, K.P.; Wardak, M.; Shao, W.; Dahlbom, M.; Kepe, V.; Liu, J.; Satyamurthy, N.; Small, G.W.; Barrio, J.R.; Huang, S.C. Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region. Eur. J. Nucl. Med. Mol. Imaging, 2010, 37(3), 575-588.
115. Ichise, M.; Ballinger, J.R.; Golan, H.; Vines, D.; Luong, A.; Tsai, S.; Kung, H.F. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J. Nucl. Med., 1996, 37(3), 513-520.
116. Ichise, M.; Liow, J.S.; Lu, J.Q.; Takano, T.; Model, K.; Toyama, H.; Suhara, T.; Suzuki, T.; Innis, R.B.; Carson, T.E. Linearized reference tissue parametric Imaging methods: Application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab., 2003, 23(9), 1096-1112.
117. Ichise, M.; Cohen, R.M.; Carson, R.E. Noninvasive estimation of normalized distribution volume: application to the muscarinic-2 ligand [18F]FP-TZTP. J. Cereb. Blood Flow Metab., 2008, 28(2), 420-430.
118. Matsumoto, R.; Ichise, M.; Ito, H.; Ando, T.; Takahashi, H.; Ikoma, Y.; Kosaka, J.; Arakawa, R.; Fujimura, Y.; Ota, M.; Takano, A.; Fukui, K.; Nakayama, K.; Suhara, T. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: A [11C]DASB PET study. Neuroimage, 2010, 49(1), 121-126.
119. Gleisner, K.S.; Nickel, M.; Linden, O.; Erlandsson, K.; Wingårdh, K.; Strand, S.E. Parametric images of antibody pharmacokinetics based on serial quantitative whole-body imaging and blood sampling. J. Nucl. Med., 2007, 48(8), 1369-1378.
120. Yaqub, M.; Tolboom, N.; Boellaard, R.; van Berckel, B.N.M.; van Tilburg, E.W.; Luurtsema, G.; Scheltens, P.; Lammertsma, A.A. Simplified parametric methods for [11C]PIB studies. Neuroimage, 2008, 42(1), 76-86.
121. Meyer, P.T.; Sattler, B.; Winz, O.H.; Fundke, R.; Oehlwein, C.; Kendziorra, K.; Hesse, S.; Schaefer, W.M.; Sabri, O. Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: A critical evaluation of the singlescan approach. Neuroimage, 2008, 42(2), 548-558.
122. Miederer, I.; Ziegler, S.I.; Liedtke, C.; Spilker, M.E.; Miederer, M.; Sprenger, T.; Wagner, K.J.; Drzezga, A.; Boecker, H. Kinetic modelling of [11C]flumazenil using data-driven methods. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(4), 659-670.
123. Gallezot, J.D.; Nabulsi, N.; Neumeister, A.; Planeta-Wilson, B.; Williams, W.A.; Singhal, T.; Kim, S.; Maguire, R.P.; McCarthy, T.; Frost, J.J.; Huang, Y.Y.; Ding, Y.S.; Carson, R.E. Kinetic modeling of the serotonin 5-HT1B receptor radioligand [11C]P943 in humans. J. Cereb. Blood Flow Metab., 2010, 30(1), 196-210.
124. Wang, G.B.; Fu, L.; Qi, J.Y. Maximum a posteriori reconstruction of the Patlak parametric image from sinograms in dynamic PET. Phys. Med. Biol., 2008, 53(3), 593-604.
125. Wang, G.B.; Qi, J.Y. Analysis of penalized likelihood image reconstruction for dynamic PET quantification. IEEE Trans. Med. Imaging, 2009, 28(4), 608-620.
126. Wang, G.B.; Qi, J.Y. Generalized algorithms for direct reconstruction of parametric images from dynamic PET data. IEEE Trans. Med. Imaging, 2009, 28(11), 1717-1726.
127. Tsoumpas, C.; Turkheimer, F.E.; Thielemans, K. A survey of approaches for direct parametric image reconstruction in emission tomography. Med. Phys., 2008, 35(9), 3963-3971.
128. Faber, T.L.; Raghunath, N.; Tudorascu, D.; Votaw, J.R. Motion correction of PET brain images through deconvolution: I. Theoretical development and analysis in software simulations. Phys. Med. Biol., 2009, 54(3), 797-811.
129. Raghunath, N.; Faber, T.L.; Suryanarayanan, S.; Votaw, J.R. Motion correction of PET brain images through deconvolution: II. Practical implementation and algorithm optimization. Phys. Med. Biol., 2009, 54(3), 813-829.
130. Wardak, M.; Wong, K.P.; Shao, W.; Dahlbom, M.; Kepe, V.; Satyamurthy, N.; Small, G.W.; Barrio, J.R.; Huang, S.C. Movement correction method for human brain PET images: Application to quantitative analysis of dynamic 18F-FDDNP scans. J. Nucl. Med., 2010, 51(2), 210-218.
131. Dawood, M.; Büther, F.; Lang, N.; Schober, O.; Schäfers, K.P. Respiratory gating in positron emission tomography: A quantitative comparison of different gating schemes. Med. Phys., 2007, 34(7), 3067-3076.
132. Dawood, M.; Büther, F.; Stegger, L.; Jiang, X.Y.; Schober, O.; Schäfers, M.; Schäfers, K.P. Optimal number of respiratory gates in positron emission tomography: A cardiac patient study. Med. Phys., 2009, 36(5), 1775-1784.
133. He, J.F.; O'Keefe, G.J.; Gong, S.J.; Jones, G.; Saunder, T.; Scott, A.M.; Geso, M. A novel method for respiratory motion gated with geometric sensitivity of the scanner in 3D PET. IEEE Trans. Nucl. Sci., 2008, 55(5), 2557-2565.
134. Lamare, F.; Cresson, T.; Savean, J.; Le Rest, C.C.; Reader, A.J.; Visvikis, D. Respiratory motion correction for PET oncology applications using affine transformation of list mode data. Phys. Med. Biol., 2007, 52(1), 121-140.
135. Lamare, F.; Carbayo, M.J.L.; Cresson, T.; Kontaxakis, G.; Santos, A.; Le Rest, C.C.; Reader, A.J.; Visvikis, D. List-mode-based reconstruction for respiratory motion correction in PET using nonrigid body transformations. Phys. Med. Biol., 2007, 52(17), 5187-5204.
136. Bai, W.J.; Brady, M. Regularized B-spline deformable registration for respiratory motion correction in PET images. Phys. Med. Biol., 2009, 54(9), 2719-2736.
137. Grotus, N.; Reader, A.J.; Stute, S.; Rosenwald, J.C.; Giraud, P.; Buvat, I. Fully 4D list-mode reconstruction applied to respiratorygated PET scans. Phys. Med. Biol., 2009, 54(6), 1705-1721.
138. Qiao, F.; Pan, T.; Clark, J.W.; Mawlawi, O.R. Region of interest motion compensation for PET image reconstruction. Phys. Med. Biol., 2007, 52(10), 2675-2689.
139. Reyes, M.; Malandain, G.; Koulibaly, P.M.; Gonzalez-Ballester, M.A.; Darcourt, J. Model-based respiratory motion compensation for emission tomography image reconstruction. Phys. Med. Biol., 2007, 52(12), 3579-3600.
140. Bettinardi, V.; Rapisarda, E.; Gilardi, M.C. Number of partitions (gates) needed to obtain motion-free images in a respiratory gated 4D-PET/CT study as a function of the lesion size and motion displacement. Med. Phys., 2009, 36(12), 5547-5558.
141. Fin, L.; Daouk, J.; Morvan, J.; Bailly, P.; El Esper, I.; Saidi, L.; Meyer, M.E. Initial clinical results for breath-hold CT-based processing of respiratory-gated PET acquisitions. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35(11), 1971-1980.
142. Torizuka, T.; Tanizaki, Y.; Kanno, T.; Futatsubashi, M.; Yoshikawa, E.; Okada, H.; Ouchi, Y. Single 20-second acquisition of deep-inspiration breath-hold PET/CT: Clinical feasibility for lung cancer. J. Nucl. Med., 2009, 50(10), 1579-1584.
143. Schleyer, P.J.; O'Doherty, M.J.; Barrington, S.F.; Marsden, P.K. Retrospective data-driven respiratory gating for PET/CT. Phys. Med. Biol., 2009, 54(7), 1935-1950.
144. Liu, C.; Pierce, L.A.; Alessio, A.M.; Kinahan, P.E. The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging. Phys. Med. Biol., 2009, 54(24), 7345-7362.
145. Chi, P.C.M.; Mawlawi, O.; Nehmeh, S.A.; Erdi, Y.E.; Balter, P.A.; Luo, D.S.; Mohan, R.; Pan, T.S. Design of respiration averaged CT for attenuation correction of the PET data from PET/CT. Med. Phys., 2007, 34(6), 2039-2047.
146. Chang, G.P.; Chang, T.T.; Pan, T.S.; Clark, J.W.; Mawlawi, O.R. Implementation of an automated respiratory amplitude gating technique for PET/CT: Clinical evaluation. J. Nucl. Med., 2010, 51(1), 16-24.
147. Khurshid, K.; McGough, R.J.; Berger, K. Automated cardiac motion compensation in PET/CT for accurate reconstruction of PET myocardial perfusion images. Phys. Med. Biol., 2008, 53(20), 5705-5718.
148. Alessio, A.M.; Kinahan, P.E.; Champley, K.M.; Caldwell, J.H. Attenuation-emission alignment in cardiac PET/CT based on consistency conditions. Med. Phys., 2010, 37(3), 1191-1200.
149. Souvatzoglou, M.; Bengel, F.; Busch, R.; Kruschke, C.; Fernolendt, H.; Lee, D.; Schwaiger, M.; Nekolla, S.G. Attenuation correction in cardiac PET/CT with three different CT protocols: a comparison with conventional PET. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34(12), 1991-2000.
150. Nye, J.A.; Esteves, F.; Votaw, J.R. Minimizing artifacts resulting from respiratory and cardiac motion by optimization of the transmission scan in cardiac PET/CT. Med. Phys., 2007, 34(6), 1901-1906.
151. Nye, J.A.; Hamill, J.; Tudorascu, D.; Carew, J.; Esteves, F.; Votaw, J.R. Comparison of low-pitch and respiratory-averaged CT protocols for attenuation correction of cardiac PET studies. Med. Phys., 2009, 36(5), 1618-1623.
152. Alessio, A.M.; Kohmyer, S.; Branch, K.; Chen, G.; Caldwell, J.; Kinahan, P. Cine CT for attenuation correction in cardiac PET/CT. J. Nucl. Med., 2007, 48(5), 794-801.
153. Green, A.J.; Francis, R.J.; Baig, S.; Begent, R.H.J. Semiautomatic volume of interest drawing for 18F-FDG image analysis-method and preliminary results. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35(2), 393-406.
154. Jentzen, W.; Freudenberg, L.; Eising, E.G.; Heinze, M.; Brandau, W.; Bockisch, A. Segmentation of PET volumes by iterative image thresholding. J. Nucl. Med., 2007, 48(1), 108-114.
155. Geets, X.; Lee, J.A.; Bol, A.; Lonneux, M.; Grégoire, V. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34(9), 1427-1438.
156. Belhassen, S.; Zaidi, H. A novel fuzzy C-means algorithm for unsupervised heterogeneous tumor quantification in PET. Med. Phys., 2010, 37(3), 1309-1324.
157. Hatt, M.; Lamare, F.; Boussion, N.; Turzo, A.; Collet, C.; Salzenstein, F.; Roux, C.; Jarritt, P.; Carson, K.; Rest, C.C.L.; Visvikis, D. Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET. Phys. Med. Biol., 2007, 52(12), 3467-3491.
158. Hatt, M.; le Rest, C.C.; Turzo, A.; Roux, C.; Visvikis, D. A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET. IEEE Trans. Med. Imaging, 2009, 28(6), 881-893.
159. Kamasak, M.E.; Bayraktar, B. Clustering dynamic PET images on the projection domain. IEEE Trans. Nucl. Sci., 2007, 54(3), 496-503.
160. Maroy, R.; Boisgard, R.L.; Comat, C.; Frouin, V.; Cathier, P.; Duchesnay, E.; Dollé, F.; Nielsen, P.E.; Trébossen, R.; Tavitian, B. Segmentation of rodent whole-body dynamic PET images: An unsupervised method based on voxel dynamics. IEEE Trans. Med. Imaging, 2008, 27(3), 342-354.
161. Maroy, R.; Boisgard, R.; Comtat, C.; Jego, B.; Fontyn, Y.; Jan, S.; Dubois, A.; Trebossen, R.; Tavitian, B. Quantitative organ time activity curve extraction from rodent PET images without anatomical prior. Med. Phys., 2010, 37(4), 1507-1517.
162. Sadik, M.; Hamadeh, I.; Nordblom, P.; Suurkula, M.; Hoglund, P.; Ohlsson, M.; Edenbrandt, L. Computer-assisted interpretation of planar whole-body bone scans. J. Nucl. Med., 2008, 49(12), 1958-1965.
163. Yu, H.; Caldwell, C.; Mah, K.; Mozeg, D. Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning. IEEE Trans. Med. Imaging, 2009, 28(3), 374-383.
164. Kono, A.K.; Ishii, K.; Sofue, K.; Miyamoto, N.; Sakamoto, S.; Mori, E. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34(9), 1490-1497.
165. Ishii, K.; Kanda, T.; Uemura, T.; Miyamoto, N.; Yoshikawa, T.; Shimada, K.; Ohkawa, S.; Minoshima, S. Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(5), 831-840.
166. Nobili, F.; Salmaso, D.; Morbelli, S.; Girtler, N.; Piccardo, A.; Brugnolo, A.; Dessi, B.; Larsson, S.; Rodriguez, G.; Pagani, M. Principal component analysis of FDG PET in amnestic MCI. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35(12), 2191-2202.
167. Fripp, J.; Bourgeat, P.; Acosta, O.; Raniga, P.; Modat, M.; Pike, K.E.; Jones, G.; O'Keefe, G.; Masters, C.L.; Ames, D.; Ellis, K.A.; Maruff, P.; Currie, J.; Villemagne, V.L.; Rowe, C.C.; Salvado, O.; Ourselin, S. Appearance modeling of 11C PiB PET images: Characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging. Neuroimage, 2008, 43(3), 430-439.
168. Markiewicz, P.J.; Matthews, J.C.; Declerck, J.; Herholz, K. Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer's disease. Neuroimage, 2009, 46(2), 472-485.
169. Razifar, P.; Engler, H.; Blomquist, G.; Ringheim, A.; Estrada, S.; Långström, B.; Bergström, M. Principal component analysis with pre-normalization improves the signal-to-noise ratio and image quality in positron emission tomography studies of amyloid deposits in Alzheimer's disease. Phys. Med. Biol., 2009, 54(11), 3595-3612.
170. Spetsieris, P.G.; Ma, Y.; Dhawan, V.; Eidelberg, D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage, 2009, 45(4), 1241-1252.